The future of Microbiome-based Medicinal Products
Milmed Unico AB’s CEO, Thomas Lenz, has participated in the Pharmabiotics Conference in Lyon 21-22 March 2023: “The Future of Microbiome-based Medicinal Products”.
Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center hosted the 8th annual 2023 Pharmabiotics Conference in Lyon, France. The conference bring in scientific and industry presentations which touch on nearly every aspect of a microbiome-based health product’s path to market, from fundamental and discovery/pre-clinical science, through translational steps and into the clinic.
Milmed Unico are a member of PRI since 2022.